DDN

Public evidence is strongest for the 2025 round, valuation, and GPU footprint. Revenue guidance and total lifetime funding rely on third-party summaries or company guidance; null denotes unsupported current disclosure.

Coverage reflects the published leadership page plus public deal communications; the full board and exact committee structure remain undisclosed.

The company and Blackstone disclose the headline round but not the full post-deal cap table. The table therefore mixes disclosed investors with economically critical stakeholders that influence the business.

This is the single chronology of record for later chapters. Historical revenue milestones come from DDN’s own timeline, while 2026 scale indicators rely on company guidance and third-party coverage.

The table separates DDN’s real addressable categories from superficially similar storage spend that does not depend on AI/HPC-grade shared data performance.

Publisher values are preserved, but the narrower DDN SAM and SOM rows are this report’s framing rather than externally published market sizes.

Buyer segmentation follows deployment model more than company size; the same vendor can appear in multiple segments depending on the workload and control requirements.

Direction reflects the net effect on DDN’s opportunity, not a universal label for every buyer segment.

The profile table focuses on the most decision-relevant competitors rather than every storage vendor with an AI webpage.

Cells are evidence-backed ordinal summaries rather than universal truth. Unknown means the retained source set did not support a clean comparison.

Most pricing remains opaque, so the table compares packaging posture and buyer leverage rather than pretending to precise list-price comparability.

Severity is an analyst judgment based on the reviewed public evidence, not a disclosed company scoring system.

Public sources support the existence of these streams but not their exact revenue contribution.

Public pricing is highly opaque, so the table records monetization posture rather than pretending to exact list prices.

These are the minimum missing items before a high-confidence financial underwriting call is possible.

Null-quality gaps are intentional; public evidence identifies the question but not the value.

Public evidence supports capital availability more than capital structure detail.

Public materials are clear on product roles but not on deployment counts or revenue weight by module.

The architecture spans both technical layers and delivery layers, which is a strength but also creates ecosystem dependencies.

Benefits are mostly company-described; independent customer-level quantification remains sparse in public materials.

Trust posture is visible conceptually, but external assurance detail is thinner than the technical-product narrative.

Public roadmap evidence in 2026 is more about announced capabilities and positioning than a full engineering roadmap.

Public segmentation is robust qualitatively but weak quantitatively; buyer, user, and payer roles are often implied rather than explicitly separated.

Trajectory is inferred from visibility and freshness of named proof, not from disclosed customer-count time series.

Rows prioritize reference quality and strategic value, not a claim that these are necessarily the largest customers by revenue.

The public record supports adoption quality better than retention quality.

The same customers that make the story credible can also make the revenue base lumpy.

Severity is based on direct effect on deal velocity, geography, or post-close liability rather than on certainty that a problem has already materialized.

Operational risk is elevated because the product is sold into environments where downtime and misconfiguration are extremely expensive.

Dependencies matter not only operationally but also in how much value DDN gets to keep as the ecosystem matures.

People risk is inferred because the public set does not expose org depth relative to platform breadth.

The risk posture can improve materially if DDN proves cohorts, controls, and product attach; absent that, price discipline must do more work.

The company quality is attractive; the gating issue is whether revenue quality and downside protection are clear enough at entry.

The recommendation is evidence-sensitive and price-sensitive, not a generic endorsement of the company.

DDN’s implied ~5x on a $1B revenue narrative sits inside the public range, but the discount for lower disclosure should remain meaningful.

Scenarios are meant to bracket valuation support, not to imply point-estimate certainty.

These are monitorable triggers that connect directly to whether DDN deserves a premium late-stage multiple.

Without these items, the recommendation should remain conditional rather than strongly affirmative.